Clinical trial
Transcranial Direct Current Stimulation as a Treatment for Motor Function in Participants Living With Progressive Supranuclear Palsy, Corticalbasal Syndrome Degeneration, or Parkinson's Disease
NCT07291687 is registered in ClinicalTrials.gov with Baycrest as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Transcranial Direct Current Stimulation as a Treatment for Motor Function in Participants Living With Progressive Supranuclear Palsy, Corticalbasal Syndrome Degeneration, or Parkinson's Disease
- Lead sponsor
- Baycrest
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- October 30, 2025
- Completion date
- December 31, 2030
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cortical basal ganglionic degeneration, parkinson disease, progressive supranuclear palsy